CD21 anticorps (APC-Cy7)
Aperçu rapide pour CD21 anticorps (APC-Cy7) (ABIN2660656)
Antigène
Voir toutes CD21 (CR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Purification
- The antibody was purified by affinity chromatography, and conjugated with APC/Cy7 under optimal conditions. The solution is free of unconjugated APC/Cy7 and unconjugated antibody.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.2 mg/mL
-
Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Protect from prolonged exposure to light. Do not freeze.
-
Stock
- 4 °C
-
Stockage commentaire
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
-
- CD21 (CR2) (Complement Component (3d/Epstein Barr Virus) Receptor 2 (CR2))
-
Autre désignation
- CD21/CD35
-
Sujet
- CD21, also known as CR2 (complement receptor 2) and C3d receptor, binds C3d and iC3b. It is also a receptor of Epstein-Barr virus. CD35, also known as CR1, binds C3b, iC3b, C4b, and iC4b. CD21/CD35 is primarily expressed on B lymphocytes, mast cells, follicular dendritic cells, macrophages, and activated granulocytes. CD21/CD35 forms part of the B-cell antigen receptor complex with CD19 and CD81 and is involved in signal transduction.
-
Pathways
- Système du Complément
Antigène
-